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Bacteria are the predominant source for producing recombinant
proteins but while many exogenous proteins are expressed, only a
fraction of those are soluble. We have found that a new actin
regulatory enzyme Mical is poorly soluble when expressed in
bacteria but the use of a Nus fusion protein tag greatly increases its
solubility. However, available vectors containing a Nus tag have
been engineered in a way that hinders the separation of target
proteins from the Nus tag during protein puriﬁcation. We have
now used recombinant DNA approaches to overcome these issues
and reengineer a Nus solubility tag-containing bacterial expression
vector. The data herein present a modiﬁed bacterial expression
vector useful for expressing proteins fused to the Nus solubility tag
and separating such target proteins from the Nus tag during pro-
tein puriﬁcation.
& 2016 The Authors. Published by Elsevier Inc. This is an open
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Value of the data
 The data provide a Nus protein fusion partner (tag) vector to increase the solubility of target
proteins expressed in bacteria.
 The data will allow for the ease of use of afﬁnity puriﬁcation-mediated separation of a target
protein from the Nus tag.
 The data will support the use of the Nus solubility tag in bacteria for target protein expression,
solubility, and puriﬁcation.1. Data
We engineered a Nus solubility tag-containing bacterial expression vector for expressing Nus
solubility-tagged proteins and then removing the Nus tag from the target protein during protein
puriﬁcation (Fig. 1). We have called this vector pET43.1bNG (Fig. 1), and this conﬁguration allows
separation of target proteins from the Nus tag following thrombin digestion and His/Nickel afﬁnity
chromatography. The data presented also allowed us to use a Nus solubility tag to increase the
solubility of Mical protein and then separate and purify His-tagged Mical protein from the Nus tag [1].2. Experimental design, materials and methods
2.1. Bacterial culture and transformation
Standard approaches for culturing bacterial cells were employed [2]. In particular, 50 μl of compe-
tent bacteria (Electromax DH10B cells; Life Technologies) was added into a 1.7 ml microcentrifuge tube.
In order to amplify the pET43.1 vector, 1 μg of pET43.1b plasmid (Novagen) was then added into the
microcentrifuge tube containing the competent bacteria. The plasmid and competent bacteria were
then incubated on ice for 30 min. Competent bacteria were then heat shocked for 1 min at 42 °C to
allow uptake of the plasmid into the bacteria. The tube was then placed on ice for 2 min. 950 μl of liquid
SOC mediumwas then added to the transformation mixture and incubated for 1 h at 37 °C in a shaking
incubator (200 rpm). 100 μl of the transformed bacteria was then spread onto luria broth (LB) agar
10 cm plates containing 50 μg/ml carbenicillin and the plates were incubated 14–16 h at 37 °C to
allow bacterial colonies to grow. A single clone from the culture plate was then selected using sterile
technique [2,3] and inoculated into 2 ml of LB culture medium containing 50 μg/ml carbenicillin and
Fig. 1. pET43.1bNG – a modiﬁed bacterial expression vector with a Nus solubility tag for expressing and purifying proteins such
as the MicalredoxCH protein.
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pET43.1b plasmid DNA using standard approaches [2].
2.2. Design and molecular biology to generate pET43.1bNG
The conﬁguration of the pET43.1 Nus- and His-tag containing vector prevented thrombin or
enterokinase-mediated separation of His-tagged target proteins from the Nus-tag, since the vector
contained His-tags on both sides of these protease sites. Therefore, we modiﬁed the pET43.1b vector to
interchange the position of the thrombin cleavage site and the N-terminal His tag. Following thrombin
digestion, this new conﬁguration allowed us to separate the target protein from the Nus tag using His/
Ni2þ afﬁnity chromatography [1]. To do this, we designed primers containing a 50 Spe I restriction
enzyme site (Forward: 50– GAC GAA GCG ACT AGT GGT TCT GGT CTG GTC CCC CGG GGC AGC TCC GCG
GGT AAA GAA ACC GCT GCT GCG –30) and a 3″ PshA I restriction enzyme site (Reverse: 50– TCC CGG ACT
CTT GTC GTC GTC ATC AAT CGT ACC AGA ACC CGC GTG ATG GTG ATG GTG ATG ACC AGT TGG CGG TGG
CGA GTC CAT GTG –30) and modiﬁed sequence based on switching the position of the thrombin
cleavage site and the N-terminal His tag. We then used PCR to amplify the short fragment and after
digestion of the appropriately sized PCR product with Spe I and PshA I, the fragment was inserted into
the Spe I (ACTAGT) and PshA I (GACAAGAGTC) sites of the pET43.1b vector. Ligation of DNA and
transformation of bacteria was then performed using standard approaches as described above. The
transformed bacteria was then spread onto LB agar 10 cm plates containing 50 μg/ml carbenicillin and
the plates were incubated 14–16 h at 37 °C to allow bacterial colonies to grow. Single clones from the
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inoculated into separate 2 ml tubes of LB culture medium containing 50 μg/ml carbenicillin and shaken
at 37 °C overnight in a shaking incubator. The overnight culture was then prepared to isolate the
pET43.1bNG plasmid DNA using standard approaches as described above, restriction enzyme digested
to conﬁrm the correct product, and sequenced on both strands.
2.3. Design and molecular biology to generate MicalredoxCH pET43.1bNG
Our work with Mical has revealed that the oxidoreductase (redox) and calponin homology (CH)
domains of Mical [4,5] are together sufﬁcient for Mical's effects on actin ﬁlaments in vivo and in vitro
with puriﬁed proteins [6–8]. Therefore, we have concentrated on working with Mical protein con-
taining both the redox and CH domains (MicalredoxCH). To generate Mical protein containing the redox
and CH domains (MicalredoxCH) in pET43.1bNG, a portion of the Mical protein containing the CH
domain was PCR ampliﬁed using primers containing a 50 Xho I restriction enzyme site (Forward: 50–
TGA CAG TCT GCT CGA GCC GTT TTG GCC CAC TGG ATC –30) and 30 Avr II restriction enzyme site
(Reverse: 50 – GTT TTA TCA GCC TAG GAA CGC CCA ACT TAA TTA ACA TTA GTG GTGGTG GTGGTG GTG
CTC GAG TCT AGA GCG AAA CAA GTC GCA GAT CTG GTC C –30) and after digestion of the appropriately
sized PCR product with Xho I and Avr II, the fragment was inserted into the Xho I and Avr II sites of a
previously generated pET43.1bNG vector containing the redox domain of Mical. This placed the CH
domain of Mical, which we had previously found to be necessary in vivo for Mical's function [6], in
frame with the redox domain. Ligation of DNA and transformation of bacteria was then performed
using standard approaches as described above. The transformed bacteria was then spread onto LB
agar 10 cm plates containing 50 μg/ml carbenicillin and the plates were incubated 14–16 h at 37 °C
to allow bacterial colonies to grow. Single clones from the culture plate were then selected using
sterile technique as described above and each clone was inoculated into separate 2 ml tubes of LB
culture medium containing 50 μg/ml carbenicillin and shaken at 37 °C overnight in a shaking incu-
bator. The overnight culture was then prepped to isolate the MicalredoxCH pET43.1bNG plasmid DNA
using standard approaches as described above, digested to conﬁrm the correct product, and
sequenced on both strands.Acknowledgements
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